Early results of dexamethasone implant, ranibizumab, and triamcinolone in macular edema due to branch retinal vein occlusion.

@article{Yumuak2016EarlyRO,
  title={Early results of dexamethasone implant, ranibizumab, and triamcinolone in macular edema due to branch retinal vein occlusion.},
  author={Erhan Yumuşak and Nesrin Buyuktortop and Kemal Ornek},
  journal={European journal of ophthalmology},
  year={2016},
  volume={26 1},
  pages={
          54-9
        }
}
PURPOSE To compare the short-term results of the efficacy and safety of dexamethasone intravitreal implant (DEX), ranibizumab (RAN), and intravitreal triamcinolone acetonide (IVTA) in macular edema secondary to branch retinal vein occlusion (BRVO). METHODS One eye each of 32 patients who were treated with intravitreal injections for macular edema secondary to BRVO was studied. This retrospective study included 3 groups. The patients received DEX in group 1 (n = 11), RAN in group 2 (n = 11… CONTINUE READING
BETA
1
Twitter Mention

Citations

Publications citing this paper.
SHOWING 1-10 OF 11 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 40 REFERENCES

Efficacy and safety of two or more dexamethasone intravitreal implant injections for treatment of macular edema related to retinal vein occlusion (Shasta study)

A JrCapone, MA Singer, DG Dodwell
  • 2014
VIEW 1 EXCERPT

Similar Papers

Loading similar papers…